arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

NanoViricides, Inc.

NNVC Health Care Biotechnology: Pharmaceutical Preparations
$1.42
▼ -6.3% Today
as of Oct 23, 10:34 ET
Last 30 days +34.76% Sep 14 → Oct 23
$1.00 $1.18 $1.37 $1.56 $1.74 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.46
High
$1.53
Low
$1.38
Volume
$145,233
Avg Vol
$491,307
Mkt Cap
$32M
P/E (TTM)
—
Beta
—
52w High
$2.23
52w Low
$0.85
Div Yield
—
Shares Out
$22M

Recent Press Releases & News last 60 days · 5 items

Oct 20 · 12:45 PR ACCESS Newswire
NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
Oct 6 · 12:45 PR ACCESS Newswire
NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026
Oct 5 · 12:45 PR ACCESS Newswire
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
▸ Show all 5 press releases & news Free account →

NNVC earnings at a glance

The options market is pricing a move of about ±160.3% after the report, a range of roughly -$0.86 to $3.70 from today's $1.42. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±2.6% on average; after the most recent report on May 14, 2026 it moved +1.2%. That means options currently expect more movement than NNVC has typically delivered. NNVC beat the consensus EPS estimate in 1 of its last 1 reported quarters. Implied volatility is currently 14%. The share price of $1.42 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.85
$2.23
41% of range
Avg surprise (last 1)
+44.4%
Avg reaction (last 2)
+2.6%
100% positive
Latest IV / EM
1357%
EM ±160.3% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.23$-0.20$-0.16$-0.12$-0.09 Actual $-0.15Actual $-0.15Actual $-0.17Actual $-0.18Actual $-0.16Actual $-0.23Actual $-0.14Actual $-0.14Actual $-0.13Actual $-0.10Est $-0.18Actual $-0.11Actual $-0.09 DecMarSepDecMarSepDecMar/2025Jun/2025Sep/2025DecMar/2026
Revenue vs Net Income Revenue Net income
$-3M$-3M$-3M$-2M$-2M Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.09 — — +35.7% +1.2% earnings
Wed Dec 31, 2025Dec 2025 $-0.11 — — — — financials
Fri Nov 14, 2025Sep/2025 $-0.10 $-0.18 +44.4% — — earnings
Mon Sep 29, 2025Jun/2025 $-0.13 — — — — earnings
Thu May 15, 2025Mar/2025 $-0.14 — — — +4.0% earnings
Tue Dec 31, 2024Dec 2024 $-0.14 — — — — financials
Mon Sep 30, 2024Sep 2024 $-0.23 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.16 — — — — financials
Sun Dec 31, 2023Dec 2023 $-0.18 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.17 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.15 — — — — financials
Sat Dec 31, 2022Dec 2022 $-0.15 — — — — financials
Fri Sep 30, 2022Sep 2022 $-0.14 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue——$0———$0—
Cost of revenue————————
Gross profit————————
Operating income$-2M$-2M$-2M—$-2M$-2M$-3M—
Net income$-2M$-2M$-2M—$-2M$-2M$-3M—
EPS (diluted)$-0.09$-0.11$-0.10—$-0.14$-0.14$-0.23—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$3M$5M$1M$2M$3M$4M$4M$5M
Inventory————————
Total current assets$3M$5M$1M$2M$3M$4M$4M$5M
Total assets$10M$12M$8M$9M$10M$12M$12M$13M
Long-term debt————————
Total liabilities$1M$1M$1M——$1M$2M—
Total equity$9M$11M$7M$8M$9M$10M$10M$11M

Implied volatility — last 90 days

399%1349%2299%3249%4199% Jun 07 — IV 589% · EM ±81.5%Jun 08 — IV 1245% · EM ±164.4%Jun 09 — IV 1340% · EM ±167.9%Jun 10 — IV 1548% · EM ±182.8%Jun 11 — IV 1585% · EM ±175.2%Jun 12 — IV 1999% · EM ±204.4%Jun 15 — IV 2337% · EM ±169.1%Jun 16 — IV 2926% · EM ±172.8%Jun 17 — IV 4199% · EM ±175.4%Jun 19 — IV 404% · EM ±89.3%Jun 22 — IV 847% · EM ±176.9%Jun 23 — IV 944% · EM ±193.2%Jun 24 — IV 899% · EM ±180.1%Jun 25 — IV 923% · EM ±180.8%Jun 26 — IV 517% · EM ±98.9%Jun 29 — IV 954% · EM ±169.1%Jun 30 — IV 933% · EM ±160.7%Jul 01 — IV 1020% · EM ±170.4%Jul 02 — IV 1092% · EM ±176.7%Jul 03 — IV 1131% · EM ±176.7%Jul 06 — IV 1122% · EM ±155.4%Jul 07 — IV 1010% · EM ±133.3%Jul 08 — IV 1107% · EM ±138.7%Jul 09 — IV 973% · EM ±114.9%Jul 10 — IV 1147% · EM ±126.7%Jul 13 — IV 1387% · EM ±115.8%Jul 14 — IV 1467% · EM ±106.2%Jul 15 — IV 1427% · EM ±84.3%Jul 16 — IV 2232% · EM ±93.2%Jul 20 — IV 400% · EM ±94.4%Jul 21 — IV 443% · EM ±103.1%Jul 22 — IV 532% · EM ±121.7%Jul 23 — IV 596% · EM ±134.0%Jul 24 — IV 657% · EM ±145.3%Jul 27 — IV 637% · EM ±133.1%Jul 28 — IV 607% · EM ±124.2%Jul 29 — IV 600% · EM ±120.1%Jul 30 — IV 675% · EM ±132.3%Jul 31 — IV 636% · EM ±121.7%Aug 03 — IV 637% · EM ±112.9%Aug 04 — IV 755% · EM ±130.0%Aug 05 — IV 858% · EM ±143.4%Aug 06 — IV 994% · EM ±160.7%Aug 07 — IV 1019% · EM ±159.3%Aug 10 — IV 1141% · EM ±158.1%Aug 12 — IV 1253% · EM ±156.9%Aug 13 — IV 1401% · EM ±165.4%Aug 14 — IV 1503% · EM ±166.1%Aug 17 — IV 1966% · EM ±164.2%Aug 18 — IV 2509% · EM ±181.5%Aug 19 — IV 2822% · EM ±166.7%Aug 20 — IV 4113% · EM ±171.8%Aug 24 — IV 980% · EM ±204.7%Aug 25 — IV 966% · EM ±197.7%Aug 26 — IV 956% · EM ±191.4%Aug 28 — IV 1032% · EM ±197.6%Aug 31 — IV 1061% · EM ±188.0%Sep 01 — IV 1272% · EM ±219.0%Sep 02 — IV 1305% · EM ±217.9%Sep 03 — IV 1400% · EM ±226.5%Sep 04 — IV 1557% · EM ±243.2%Sep 07 — IV 1740% · EM ±241.1%Sep 08 — IV 1910% · EM ±252.3%Sep 09 — IV 2090% · EM ±261.9%Sep 10 — IV 2490% · EM ±294.1%Sep 11 — IV 2504% · EM ±276.7%Sep 14 — IV 3250% · EM ±271.4%Sep 16 — IV 4021% · EM ±237.5%Sep 17 — IV 4190% · EM ±175.0%Sep 22 — IV 783% · EM ±160.1%Sep 23 — IV 624% · EM ±125.0%Sep 24 — IV 727% · EM ±142.4%Sep 25 — IV 780% · EM ±149.3%Sep 29 — IV 911% · EM ±156.8%Sep 30 — IV 1028% · EM ±171.8%Oct 01 — IV 1144% · EM ±185.0%Oct 02 — IV 1275% · EM ±199.2%Oct 06 — IV 1109% · EM ±146.4%Oct 07 — IV 1192% · EM ±149.3%Oct 08 — IV 1357% · EM ±160.3%

Sector peers

VYNE
VYNE Therapeutics Inc.
$31M $28.56
MIRA
MIRA Pharmaceuticals, Inc.
$30M $0.62-8.6%
NXTC
NextCure, Inc.
$30M $4.70-13.2%
RMTI
Rockwell Medical, Inc.
$35M $7.48+5.6%
BCTX
BriaCell Therapeutics Corp.
$35M $3.40-5.6%
CNTX
Context Therapeutics Inc.
$29M $0.23-0.4%

NNVC earnings FAQ

What is NNVC's expected move for earnings?

Options currently price a move of about ±160.3%, or $2.28 per share either way from $1.42.

How does NNVC stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.6%, up 2 times and down 0 times.

What is NNVC's implied volatility?

NNVC's at-the-money implied volatility is about 14% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in